1. People's Republic of China Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
Beijing Dbn Technology Group Co., Ltd. Class A

Beijing Dbn Technology Group Co., Ltd. Class A

002385.SZ
Beijing Dbn Technology Group Co., Ltd. Class ACN flagShenzhen Stock Exchange
2.97
CNY
+0.07
- -
12.77BMarket Cap
Beijing Dbn Technology Group Co., Ltd. Class A
002385.SZ
(Shenzhen Stock Exchange)

Recent

price

2.97

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.54
2.18
2.94
4.62
4.95
4.34
4.2
4.59
4.57
3.88
5.6
7.83
6.34
8.14
6.66
6.81
6.53
Revenue per Share
0.09
0.14
0.19
0.21
0.21
0.19
0.22
0.31
0.12
0.12
0.48
-0.11
0.01
-0.53
0.08
-0.15
0.16
Basic EPS, GAAP
0.03
0.06
-0.06
-0.26
-0.04
0.04
-0.06
-0.09
0.02
0.22
-0.14
-0.3
-0.03
-0.2
0.37
- -
-0.19
Free Cash Flow per Basic Share
0.03
0.03
0.03
0.05
0.06
0.08
0.08
0.09
0.18
0.15
0.3
0.14
0.08
0.21
0.16
0.12
0.14
Dividend per Share
0.29
0.38
0.64
1.03
1.16
1.58
1.95
2.19
2.07
2.08
2.41
2.26
1.78
1.58
1.55
1.39
1.55
Book Value per Share
0.88
0.93
1.06
1.29
1.43
1.98
2
2.32
1.98
2.15
2.67
2.66
2.03
1.71
1.77
1.58
1.76
Tangible Book Value per Share
3,414
3,596
3,617
3,605
3,730
3,713
4,012
4,081
4,224
4,277
4,074
4,003
5,108
4,102
4,322
4,277
4,478
Basic Weighted Avg Shares
5,248
7,836
10,640
16,661
18,445
16,098
16,841
18,742
19,302
16,578
22,814
31,328
32,397
33,390
28,767
29,119
29,232
Sales/Revenue/Turnover
6.84
7.59
7.36
5.78
5.53
5.14
6.85
8.29
3.94
5.72
11.22
0.59
2.77
-1.08
3.97
2.28
5.06
Operating Margin (%)
56
78
114
173
272
373
409
417
502
517
711
1,009
1,095
1,055
1,151
1,122
- -
Depreciation Expense
311
504
675
769
796
706
883
1,265
507
513
1,956
-440
51
-2,174
346
-642
737
Net Income, GAAP
16.76
15.29
15.99
19.39
16.52
18.12
16.28
15.89
25.88
11.85
8.13
- -
1.19
- -
7.11
- -
4.37
Effective Tax Rate (%)
5.93
6.43
6.35
4.62
4.31
4.38
5.24
6.75
2.63
3.1
8.57
-1.41
0.16
-6.51
1.2
-2.2
2.52
Profit Margin (%)
2,289
2,306
2,041
1,521
2,112
3,510
3,067
2,333
479
1,214
838
293
-904
-4,723
-4,143
-3,813
-3,281
Working Capital
5
4
7
4
499
499
499
500
694
1,250
2,416
3,256
3,341
2,928
2,334
3,048
2,993
LT Debt
3,182
3,590
4,283
5,292
6,297
9,259
10,028
11,767
10,694
11,463
12,988
12,706
13,021
10,039
10,649
9,687
10,853
Total Equity
13.29
14.65
16.44
14.78
12.26
7.51
8.99
10.37
3.99
5.68
13.28
- -
3.93
- -
4.77
- -
6.15
Return on Invested Capital (%)
27.98
36.41
31.85
21.36
15.95
11.78
10.67
11.91
5.45
4.33
9.35
- -
1.2
- -
2.67
- -
3.63
Return on Capital (%)
35.99
42.33
36.68
25.56
19.83
13.85
12.87
15.07
5.73
5.82
20.9
-4.67
0.56
-27.93
5.24
-10.14
11.1
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
9,196
10,199
10,090
LT Borrowings
1,942
2,740
2,616
LT Finance Leases
392
383
376
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4,300
4,300
4,300
Market Capitalization
18,139
17,777
18,090

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
10,507
11,751
11,642
Cash, Cash Equivalents & STI
4,139
4,933
4,866
Accounts Receivable, Net
1,000
1,399
1,381
Inventories
4,569
4,425
4,495
Total Current Liabilities
14,650
14,870
14,923
Payables & Accruals
- -
- -
- -
ST Debt
9,196
10,199
10,090
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.15%
-5.11%
-9.03%
Free Cash Flow
64.31%
21.41%
-98.82%
Net Income, GAAP
-470.06%
-998.28%
-285.53%
Sales/Revenue/Turnover
7.36%
6.23%
1.22%
Total Cash Common Dividend
18.99%
-2.55%
-24.24%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,707
6,388
7,047
8,625
28,767
2025
6,865
6,694
8,375
- -
29,119
2026
7,191
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
- -
- -
- -
0.08
2025
0.03
- -
- -
- -
-0.15
2026
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
- -
- -
- -
0.16
2025
0.02
- -
- -
- -
0.12
2026
0.02
- -
- -
- -
- -
Similar Companies
Highfield Resources Limited (HFR.AX)
Hindustan Motors Limited (HINDUST.BO)
PM Thoresen Asia Holdings Public Company Limited (PMTA.BK)
Insecticides (India) Limited (INSECTICID.BO)
Bharat Rasayan Limited (BHARATRAS.BO)
MustGrow Biologics Corp. (MGROF)
Business
Beijing Dabeinong Technology Group Co., Ltd. is a leading Chinese agricultural technology company specializing in the production and sales of animal nutrition products, animal feed, crop seeds, and agricultural biotechnology solutions. The company offers a comprehensive range of core products that include formulated animal feeds for swine, poultry, and aquatic species; hybrid seeds for rice, corn, and cotton; feed additives; biological breeding technologies; and seed treatment products. It operates primarily in China with expanding international reach, supported by proprietary technologies and over 840 patents in the fields of animal nutrition, feed, and crop biotechnology. Founded in 1994 and headquartered in Beijing, the company also has a significant presence in agricultural biotechnology through its subsidiary Beijing Dabeinong Biotechnology Co., Ltd., which focuses on crop productivity and sustainable agriculture. Recent major developments include a strategic acquisition announced in early 2024, whereby Beijing Dabeinong acquired full ownership of three and majority stakes in five animal feed subsidiaries from Jiangxi Zhengbang Technology to enhance its competitiveness and increase market share in animal feed. The company achieved a notable operational milestone in 2025 with an expected annual hog output exceeding 8 million heads, while successfully reducing fully-loaded costs per kilogram. Financially, it reported a year-on-year revenue increase for the first nine months of 2025 to approximately RMB 20.7 billion and a net profit attributable to shareholders of RMB 2.57 billion through September 2025. Its pig farming segment returned to profitability in 2025 after four years, driven by effective cost control and expanded sales of rice and corn seeds which more than doubled and tripled respectively compared to the previous year. Additionally, Beijing Dabeinong continues to innovate in biotechnology, securing regulatory approvals for genetically modified soybean varieties in international markets such as Uruguay and Argentina. The company has also increased its equity stake in its biotechnology subsidiary to strengthen integration of crop biotech and seed innovation within its portfolio. These advancements position Beijing Dabeinong as a key integrated agriculture solution provider targeting a sustainable and innovation-driven growth strategy in the feed, seed, and biotech sectors.